Anti-Inflammatory Properties of Irisin, Mediator of Physical Activity, Are Connected with TLR4/MyD88 Signaling Pathway Activation

Irisin acts as a regulator of macrophages host defense

(2017) Agnieszka Irena Mazur-Bialy   LIFE SCIENCES

Adipose tissue macrophages: going off track during obesity

(2016) Lily Boutens et al.   DIABETOLOGIA

Elevated circulating irisin is associated with lower risk of insulin resistance: association and path analyses of obese Chinese adults

(2016) Xiulin Shi et al.   BMC Endocrine Disorders

New markers of insulin resistance in polycystic ovary syndrome

(2016) K. Polak et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

FNDC5 expression and circulating irisin levels are modified by diet and hormonal conditions in hypothalamus, adipose tissue and muscle

(2016) B. M. Varela-Rodríguez et al.   Scientific Reports

Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism

(2015) Amaia Rodríguez et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Irisin, a novel myokine is an independent predictor for sarcopenia and carotid atherosclerosis in dialysis patients

(2015) Mi Jung Lee et al.   ATHEROSCLEROSIS

Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics

(2015) Xeni Provatopoulou et al.   BMC CANCER

Skeletal muscle as an endocrine organ: PGC-1α, myokines and exercise

(2015) Svenia Schnyder et al.   BONE

New role of irisin in hepatocytes: The protective effect of hepatic steatosis in vitro

(2015) Min-Jung Park et al.   CELLULAR SIGNALLING

The whole body cryostimulation modifies irisin concentration and reduces inflammation in middle aged, obese men

(2015) Katarzyna Dulian et al.   CRYOBIOLOGY

The “Big Bang” in obese fat: Events initiating obesity-induced adipose tissue inflammation

(2015) Felix M. Wensveen et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues

(2015) J Dong et al.   INTERNATIONAL JOURNAL OF OBESITY

Irisin: a new molecular marker and target in metabolic disorder

(2015) Jia-qi Chen et al.   Lipids in Health and Disease

Irisin and Myonectin Regulation in the Insulin Resistant Muscle: Implications to Adipose Tissue: Muscle Crosstalk

(2015) Luis Gamas et al.   Journal of Diabetes Research

Circulating Irisin Levels Are Positively Associated with Metabolic Risk Factors in Sedentary Subjects

(2015) María Moreno et al.   PLoS One

Plasma irisin levels predict telomere length in healthy adults

(2014) Karan S. Rana et al.   AGE

Irisin: ‘fat’ or artefact

(2014) A.B. Crujeiras et al.   CLINICAL ENDOCRINOLOGY

Macrophages, Immunity, and Metabolic Disease

(2014) Joanne C. McNelis et al.   IMMUNITY

Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans

(2014) J Y Huh et al.   INTERNATIONAL JOURNAL OF OBESITY

Crosstalk between Adipocytes and Immune Cells in Adipose Tissue Inflammation and Metabolic Dysregulation in Obesity

(2014) Jin Young Huh et al.   MOLECULES AND CELLS

Irisin as a muscle-derived hormone stimulating thermogenesis – A critical update

(2014) Tobias Hofmann et al.   PEPTIDES

Three new players in energy regulation: Preptin, adropin and irisin

(2014) Suleyman Aydin   PEPTIDES

Higher baseline irisin concentrations are associated with greater reductions in glycemia and insulinemia after weight loss in obese subjects

(2014) P Lopez-Legarrea et al.   Nutrition & Diabetes

Irisin Stimulates Browning of White Adipocytes Through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling

(2013) Y. Zhang et al.   DIABETES

Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance

(2013) José María Moreno-Navarrete et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Lower circulating irisin is associated with type 2 diabetes mellitus

(2013) Jian-Jun Liu et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Irisin in patients with nonalcoholic fatty liver disease

(2013) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

FNDC5/Irisin Is Not Only a Myokine but Also an Adipokine

(2013) Arturo Roca-Rivada et al.   PLoS One

Decrease in Irisin in Patients with Chronic Kidney Disease

(2013) Ming-Shien Wen et al.   PLoS One

Irisin, Two Years Later

(2013) Marta G. Novelle et al.   International Journal of Endocrinology

Adaptive immunity in obesity and insulin resistance

(2012) Henrike Sell et al.   Nature Reviews Endocrinology

Muscles and their myokines

(2010) B. K. Pedersen   JOURNAL OF EXPERIMENTAL BIOLOGY

Adaptive immunity and adipose tissue biology

(2010) Denise A. Kaminski et al.   TRENDS IN IMMUNOLOGY

Mutational analysis of Cys88 of Toll-like receptor 4 highlights the critical role of MD-2 in cell surface receptor expression

(2009) C. Nishitani et al.   INTERNATIONAL IMMUNOLOGY

Adipose Tissue Macrophages, Low Grade Inflammation and Insulin Resistance in Human Obesity

(2008) Leonie Heilbronn et al.   CURRENT PHARMACEUTICAL DESIGN

LPS/TLR4 signal transduction pathway

(2008) Yong-Chen Lu et al.   CYTOKINE